Beijing Science Sun Pharmaceutical Co.,Ltd.’s Net Profit Dropped 48.7% in 2022

Beijing Science Sun Pharmaceutical Co.,Ltd. (北京赛升药业股份有限公司) (300485.SZ) reported a net profit of 202.6 million yuan in 2022, down 48.7% year-on-year.

Meanwhile, the company posted 734.5 million yuan in revenue, down 30.1% year-on-year.

At the end of the reporting period, it had 3.6 billion yuan in total assets and 157.1 million yuan in total liabilities, with a liability-to-asset ratio of 4.4%.